Fig. 3From: Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patientsFrequency distribution of phenotypic and molecular test results to determine Carbapenem-resistant K. pneumoniae (CRKP) clinical isolatesBack to article page